[Whipple's disease and reversible pulmonary hypertension]

Sonia Pankl1, Milagros Báez1, Pablo Young1

  • 1Servicio de Clínica Médica, Hospital Británico de Buenos Aires, Argentina.

Medicina
|February 21, 2021
PubMed

Insights

Whipple's disease, a rare bacterial infection, presents diagnostic challenges due to nonspecific symptoms. Early diagnosis and treatment are crucial for improving patient prognosis in this multisystemic condition.

Area of Science:

  • Infectious Diseases
  • Gastroenterology
  • Rheumatology

Background:

  • Whipple's disease is a rare, chronic, multisystemic infectious disease caused by Tropherima whipplei.
  • It primarily affects middle-aged males, with an estimated global incidence of 9.8 cases per million.
  • Diagnosis is challenging due to nonspecific clinical features and varied organ involvement.

Purpose of the Study:

  • To present a case of Whipple's disease with extensive multisystem compromise.
  • To highlight the diagnostic challenges and emphasize the importance of early recognition.
  • To contribute to the limited case documentation from South America.

Main Methods:

  • Case report presentation.
  • Confirmation of diagnosis through histopathology.
  • Review of relevant literature regarding Whipple's disease.

Main Results:

  • The case presented demonstrated significant multisystemic involvement.
  • Histopathological findings confirmed the diagnosis of Whipple's disease.
  • The rarity of documented cases in South America underscores the need for increased awareness.

Conclusions:

  • Whipple's disease requires a high index of suspicion for timely diagnosis.
  • Prompt treatment initiated after early diagnosis significantly improves prognosis.
  • This case report adds valuable data from a region with limited documentation.

Related Concept Videos

Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
410
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
183
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.2K
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
250
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
312
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
169